Slipknot bassist died of “accidental” overdose

(Reuters) – The bassist for the Grammy-winning metal band Slipknot died of an “accidental” overdose of morphine and fentanyl, a synthetic morphine substitute, police in Iowa said on Monday as autopsy results were released.

Entertainment | Music | People

Paul Gray, 38, was found dead on May 25 at a hotel near Des Moines, Iowa, the hometown of the band who always appear in public in grotesque masks, beat each other up on stage and call their fans “maggots.” Gray co-founded the band in 1995.

An autopsy conducted by the Polk County Medical Examiner’s Office also found that Gray suffered from “significant heart disease,” according to a statement released by the Urbandale police department.

After Gray’s death the eight surviving members of the band shocked fans by appearing in public for the first time without their trademark masks and coveralls to pay tribute to him. They were accompanied by Gray’s wife Brenna who is pregnant with their first child.

Slipknot topped the charts in the United States, Britain and Australia with its most recent album, 2008′s “All Hope Is Gone.” The band won a Grammy in 2004 for its song “Before I Forget.”

The band also became notorious for its performances in which members often broke each other’s bones, set each other on fire, and injured their fans after diving into the crowd.

(Writing by Belinda Goldsmith, Editing by Dean Goodman)

New hope for patients at high risk of recurrences of heart disease

Washington, May 20 (ANI): Canadian researchers have confirmed the potential of a medication to reduce inflammation in patients with atherosclerosis.

The results of the clinical study, directed by Dr. Jean-Claude Tardif of the Montreal Heart Institute (MHI), have appeared in the journal Circulation Cardiovascular Imaging.

The promising findings of this study on VIA-2291 – a medication developed by Via Pharmaceuticals, a San Francisco-based biotechnology firm – relate to its capacity to effectively reduce inflammation, which can contribute to the formation and progression of atherosclerosis plaque and infarct.

Dr. Tardif said: “Up to now, standard treatments for patients with acute coronary syndrome (unstable angina and infarct) have not specifically reduced inflammation, an important component of atherosclerosis. However, research in recent years has allowed us to determine that the presence of inflammation significantly increases the risk of recurrence among these patients. The clinical study was conducted with about 200 patients, and the findings we””re publishing show that VIA-2291 may finally offer the solution we need to target and reduce inflammation. In fact, these newly published data strongly support the evaluation of VIA-2291 in larger outcome trials.”

The Montreal Heart Institute””s Research Centre directed the study in several hospitals in Canada and the United States as well as analysed all of the data, including data collected by CAT scans of coronary arteries.

Dr. Tardif added: “The publication of this new study attests once again to the excellence of the entire team at the Montreal Heart Institute””s Research Centre. While we””re clearly satisfied with the findings obtained with VIA-2291, we””re even more thrilled at the prospect of taking a big step toward more effective and personalized prevention of cardiovascular disease.” (ANI)

Genes that let you live to 100 discovered

London, May 16 (ANI): The secret to longevity probably lies in having the right ‘suite’ of genes, according to new studies of centenarians and their families.

Scientists have identified the ‘Methuselah’ genes whose carriers have a much-improved chance of living to 100 despite indulging in an unhealthy lifestyle.

The so-called Methuselah genes— named after the biblical patriarch who lived to 969 — protect people against the effects of smoking and bad diet and can also delay the onset of age-related illnesses such as cancer and heart disease by up to three decades.

“Long-lived people do not have fewer disease genes or ageing genes. Instead they have other genes that stop those disease genes from being switched on. Longevity is strongly genetic and inherited,” The Times quoted study’s lead author Eline Slagboom of Leiden University, as saying.

The genes are thought to include ADIPOQ, which is found in about 10 percent of young people but in nearly 30 percent of people living past 100.

The CETP gene and the ApoC3 gene are found in 10 percent of young people, but in about 20 percent of centenarians.

The studies show that tiny mutations in the make-up of particular genes can sharply increase a person’s lifespan. Nonetheless, environmental factors such as the decline in infectious diseases are an important factor in the steady rise in the number of centenarians.

Dr David Gems, a longevity researcher at University College London, believes that treatments to slow ageing will become widespread.

“If we know which genes control longevity then we can find out what proteins they make and then target them with drugs. That makes it possible to slow down ageing. We need to reclassify it as a disease rather than as a benign, natural process. Much of the pain and suffering in the world are caused by ageing. If we can find a way to reduce that, then we are morally obliged to take it,” he said. (ANI)

Why men store fat in their bellies, women in their hips

Washington, May 15 (ANI): Researchers claim to have answered the age-old question of why men store fat in their bellies and women store it in their hips – the fat tissue is almost completely different, genetically speaking that is.

“We found that out of about 40,000 mouse genes, only 138 are commonly found in both male and female fat cells,” said Dr. Deborah Clegg, assistant professor of internal medicine at UT Southwestern Medical Center and senior author of the study appearing in the International Journal of Obesity. “This was completely unexpected. We expected the exact opposite – that 138 would be different and the rest would be the same between the sexes.”

The study involved mice, which distribute their fat in a sexually dimorphic pattern similar to humans.

“Given the difference in gene expression profiles, a female fat tissue won”t behave anything like a male fat tissue and vice versa,” Dr. Clegg said. “The notion that fat cells between males and females are alike is inconsistent with our findings.”

In humans, men are more likely to carry extra weight around their guts while pre-menopausal women store it in their butts, thighs and hips.

The bad news for men is that belly, or visceral, fat has been associated with numerous obesity-related diseases including diabetes and heart disease. Women, on the other hand, are generally protected from these obesity-related disorders until menopause, when their ovarian hormone levels drop and fat storage tends to shift from their rear ends to their waists.

“Although our new findings don”t explain why women begin storing fat in their bellies after menopause, the results do bring us a step closer to understanding the mechanisms behind the unwanted shift,” Dr. Clegg said.

For the study, researchers used a microarray analysis to determine whether male fat cells and female fat cells were different between the waist and hips and if they were different based on gender at a genetic level.

Because the fat distribution patterns of male and female mice are similar to those of humans, the researchers used the animals to compare genes from the belly and hip fat pads of male mice, female mice and female mice whose ovaries had been removed – a condition that closely mimics human menopause. Waist and hip fat (subcutaneous fat) generally accumulates outside the muscle wall, whereas belly fat (visceral fat), a major health concern in men and postmenopausal women, develops around the internal organs.

In addition to the genetic differences among fat tissues, the researchers found that male mice that consumed a high-fat diet for 12 weeks gained more weight than female mice on the same diet. The males” fat tissue, particularly their belly fat, became highly inflamed, while the females had lower levels of genes associated with inflammation. The female mice whose ovaries had been removed, however, gained weight on the high-fat diet more like the males and deposited this fat in their bellies, also like the males.

“The fat of the female mice whose ovaries had been removed was inflamed and was starting to look like the unhealthy male fat,” Dr. Clegg said. “However, estrogen replacement therapy in the mice reduced the inflammation and returned their fat distribution to that of mice with their ovaries intact.”

Dr. Clegg said the results suggest that hormones made by the ovaries may be critical in determining where fat is deposited. (ANI)

Women derive double benefit from heart failure device than men

Washington, May 14 (ANI): Women show better results than men with device therapy to prevent the progression of mild heart failure, according to a study.

Women with mild heart disease who had a cardiac resynchronization device combined with a defibrillator (CRT-D) implanted had a 70 percent reduction in heart failure alone and a 72 percent reduction in death from any cause.

Men received some benefit from the therapy, but not the out-of-the-park results seen in women.

“This is the first study in which a heart failure therapy has proven more effective in women than in men,” said cardiologist Dr. Arthur Moss, professor of Medicine at the University of Rochester Medical Center and lead author of the study.

Researchers found that females receiving CRT-D therapy to prevent heart failure progression had significantly better outcomes than males receiving the therapy.

Reduction of heart failure in females was twice that of males – 70 percent versus 35 percent.

While women saw a significant 72 percent reduction in death from any cause, there was no evident reduction in men.

This gender-based analysis comes less than two months after an advisory panel to the U.S. Food and Drug Administration recommended that the device, which is developed by Boston Scientific, be approved for use in patients with mild heart failure.

The device is already approved to treat patients with severe heart failure.

If approved for the new prevention of heart failure indication, nearly 4 million more Americans could be candidates for treatment with the CRT-D.

“Anecdotally, we know that women are offered devices to treat heart failure less often than men. We”re hopeful that these results will change the mindset of physicians and that they will apply this type of therapy as indicated in women as well as in men,” said Dr. Wojciech Zareba, co-author of the study.

In women with mild heart failure, CRT-D therapy effectively prevented deterioration of the heart, otherwise known as cardiac remodelling.

The study was presented at the Heart Rhythm Society”s 31st Annual Scientific Sessions. (ANI)

Low vitamin D tied to depression in older people

Reuters Older men and women with lower levels of vitamin D in their blood are more prone to become depressed over time, new research shows.

Many studies have been published recently on the potential health benefits of vitamin D, and the potential risks of deficiency. Low vitamin D levels have been linked to heart disease, stroke, high blood pressure, and more severe asthma.

In older people, insufficient vitamin D is quite common, and has been linked to fractures, worse physical function, greater frailty, and a wide variety of chronic illness.

In the current study, Dr. Luigi Ferrucci of the National Institute on Aging in Baltimore and colleagues looked at whether low vitamin D levels and depression in older people might be related.

They followed 531 women and 423 men 65 and older who were participating in the InCHIANTI Study, a long-term investigation of factors associated with loss of mobility in aging people, over six years.

At the study’s outset, 42 percent of the women and 18 percent of the men were depressed, while three-quarters of the women and half of the men had levels of vitamin D below 50 nanomoles per liter, which is generally considered insufficient.

Seventy-two percent of the depressed people and 60 percent of the non-depressed people had vitamin D insufficiency – the level above deficiency — the researchers found. Women with vitamin D insufficiency showed a worse decline in mood at three and six years into the study; their scores on a standardized test measuring depressive symptoms increased more at three and six years compared to the scores for women who had adequate vitamin D. This increase could have tipped the scale into a diagnosis of depression for some people.

Women with low vitamin D who weren’t depressed at the beginning of the study were also twice as likely to become depressed over the following six years as the women who had sufficient levels of the nutrient. While similar patterns were seen for men, the association wasn’t as strong, and in some cases could have been due to chance, according to the researchers.

The study does not prove that low vitamin D levels cause depression, the authors note; people with low levels of the nutrient might have other characteristics that predispose them to the blues.

Still, they suggest that preventing “vitamin D deficiency in the elderly may become in the future a strategy to prevent the development of depressive mood in the elderly and avoid its deleterious consequences on health. In addition, normalization of vitamin D levels may be part of any depression treatment plans in older patients.”

Vitamin D, produced by the body when skin is exposed to sunlight, is also found in certain foods such as oily fish. It helps cells absorb calcium and is important for bone health.

However, the authors conclude, before any strategies to boost vitamin D can be adopted they must be tested in larger and more rigorously designed trials.

Improvements in cholesterol levels, BP linked to lower rate of heart disease deaths

Washington, May 12 (ANI): Deaths from coronary heart disease (CHD) fell by 35 per cent in Ontario between 1994 and 2005, thanks to improvements in both lifestyle factors and medical treatments, a new research has shown.

The results of the study suggest that improvements in cholesterol levels and blood pressure were responsible for about half of the reduction in deaths, while new medical and surgical treatments took credit for most of the rest of the decrease.

“Coronary heart disease remains the most common cause of death worldwide and generates a large economic burden. Rates of CHD mortality have decreased substan­tially over the last 3 decades,” the authors said.

“Identifying the underlying factors associated with this decline is critical for planning future health policy, and pri­oritizing strategies for primary and sec­ondary prevention,” they added.

Harindra C. Wijeysundera, of the Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada, and colleagues conducted the study.

The study has been published in the May 12 issue of JAMA. (ANI)

Working overtime raises heart disease risk

Washington, May 12 (ANI): Clocking in overtime may adversely affect a healthy heart, says a new study.

The results, from the long-running study following more than 10,000 civil servants in London (UK): the Whitehall II study, are published in the European Heart Journal .

The study found that, compared with people who did not work overtime, people who worked three or more hours longer than a normal, seven-hour day had a 60 percent higher risk of heart-related problems such as death due to heart disease, non-fatal heart attacks and angina.

Dr Marianna Virtanen, an epidemiologist at the Finnish Institute of Occupational Health, Helsinki (Finland) and University College London (UK), said: “The association between long hours and coronary heart disease was independent of a range of risk factors that we measured at the start of the study, such as smoking, being overweight, or having high cholesterol.

“Our findings suggest a link between working long hours and increased CHD [coronary heart disease] risk, but more research is needed before we can be confident that overtime work would cause CHD. In addition, we need more research on other health outcomes, such as depression and type 2 diabetes.” (ANI)

‘No cardiovascular health benefit from chocolate, coffee, red wine’

Wellington, May 11 (ANI): The Australian Heart Foundation has revealed that there is no cardiovascular health benefit from eating chocolate or drinking coffee or red wine, even though they contain antioxidants.

Susan Anderson, the Heart Foundation’s national director of healthy weight, said a review of more that 100 scientific papers found that even though the three were commonly referred to as part of a heart healthy diet, they were not.

“Chocolate, coffee and red wine are okay as part of a balanced diet,” the New Zealand Herald quoted Anderson as saying in a statement released May 11.

“But these findings confirm that if you’re consuming them thinking you’re reducing your risk of heart disease then think again.

“The best way to get enough antioxidants is to eat a variety of plant-based foods such as vegetables, fruit, legumes, wholegrain breads and cereals, nuts and seeds every day,” she stated.

She went on to says that people were best advised to eat at least two serves of fruit and five serves of vegetables every day.

Tea on the other hand was confirmed as helping to lower heart attack risk, though where milk was added it should be reduced, low or no fat.

There was insufficient evidence to recommend eating either milk or dark chocolate, drinking coffee, red wine or other alcoholic drinks or use antioxidant supplements, such as vitamins E and C.

Anderson said there were widespread misconceptions about which foods were positive for cardiovascular health, and the results of the review would be sent to doctors and other health professionals. (ANI)

Soon, ‘magic pill’ that will allow people to live beyond 100

London, May 11 (ANI): Scientists are developing a new pill, which, if taken at 40, could boost a person’s chances of living longer.

Prof Nir Barzilai, director of the Institute of Ageing at the Albert Einstein College of Medicine in New York, said that one can go on to live for 100 years despite following a poor diet and even smoking, only if their genes are programmed for longevity.

Those who lived very long lives were genetically programmed to do so, which insulated them from the effects of “environmental” factors like smoking and a poor diet.

The professor studied 500 Jewish people between 95 and 112.

“These people smoked, they are overweight, they have high cholesterol,” the Telegraph quoted him as saying.

He said about 30 per cent of them were obese, while 30 per cent of them had smoked to the age of 95.

“They are protected from the environment by their genotype,” he said.

Living a healthy life might help most people increase their life expectancy by a few years, but it won’t be of any use for those who wanted to live much longer, he said.

His findings support anecdotal stories of countless people who have lived to a grand old age seemingly in spite of smoking, lack of exercise or a poor diet.

He said that centenarians tended to have genes, which delayed the onset of age-related illnesses like heart disease and Alzheimer”s.

“When they eventually die, they die of the same things that people die of in their 70s or 80s. It”s just that they die 30 years later,” he said.

Identifying these genes opened the doorway to developing longevity drugs, which mimicked their effects, he said.

The researchers have already identified a number of such genes among the centenarians.

Laboratories are now working on creating a drug which mimics the effects of three of them – two that increase the production of so-called ”good” cholesterol in the body, which reduces the risk of heart disease and stroke, and a third that helps prevent diabetes.

Barzilai said that testing could begin by 2012, with it appearing on the market “within five or 10 years”.

“People will take a pill, starting at 40, and their lives will be longer,” he predicted.

Barzilai will address the Royal Society in London on the subject of ”interfering with ageing to treat ageing-related disease”. (ANI)

Raised blood fat levels tied to heart disease

London, May 7 (ANI): Raised levels of triglycerides, a type of blood fat, may be an important cause of heart disease, new genetic research suggests.

To reach the conclusion, Cambridge University boffins looked at the role of triglycerides, which is produced in the liver and derived from foods such as meat and dairy products, the Lancet medical journal reported.

According to the analysis of 350,000 people from 101 previous studies, those with higher levels of the blood fat were more likely to have heart disease.

Lead researcher Dr Nadeem Sarwar said the findings suggested the blood fat could be causing heart disease in some way, reports The BBC.

“Such trials should help establish whether lowering triglyceride levels can reduce the risk of heart disease.”

Mike Knapton, of the British Heart Foundation, said: “It could yet prove to be an important step towards tackling cardiovascular disease but we mustn”t get ahead of ourselves.

“There still needs to be larger trials before we can know whether lowering triglyceride levels can reduce heart disease risks.

“For now, people should continue to follow advice on diet, exercise, stopping smoking and medication which are still the best ways to tackle your heart disease risk.” (ANI)

Ready-to-eat cereals and bread with wheat aleurone ‘good for health’

Washington, May 6 (ANI): A new study has offered evidence that consuming wheat aleurone as part of ready-to-eat cereals and bread is good for health.

Wheat aleurone is a novel wheat grain fraction with high levels of potentially health-promoting compounds.

New clinical trials with ready-to-eat cereals and bread containing wheat aleurone have been performed, and showed increased blood concentrations of tentatively beneficial compounds such as betaine, and decreased homocysteine and LDL-cholesterol which are both associated with heart disease risk.

Buhler produced aleurone fractions in their pilot production plants in Switzerland, which were then incorporated into ready-to-eat cereal by Buhler, and into bread rolls by Barilla in Italy. These products contained 9 g aleurone per portion.

The University of Ulster in Northern Ireland, UK conducted a 4-week randomised controlled clinical study with human subjects, who consumed two portions of bread rolls, and one portion of ready-to-eat cereal as part of their diets.

The study showed that, compared to control products, the consumption of the products, which provided 27 g aleurone per day, led to significant changes in a number of plasma biomarkers.

Betaine increased, and there were decreases in homocysteine and LDLcholesterol, which are both associated with heart disease risk.

Furthermore, there was a decrease in C-reactive protein (CRP), which is a biomarker for inflammation. (ANI)

Now, software that decodes emotions over the phone

Washington, May 6 (ANI): An Israeli company called eXaudios has developed a new computer program that can not only predict a caller”s emotional state over the phone, but may also diagnose a range of medical conditions.

The program, known as Magnify, decodes the human voice to identify a person”s emotional state.

Some U.S. companies already use the system in their call centers. eXaudios is even testing the software”s use in diagnosing medical conditions like autism, schizophrenia, heart disease and even prostate cancer.

“When agents talk with customers over the phone, they usually focus on content and not intonation, unless the customer is screaming,” Discovery News quoted Yoram Levanon, President and CEO of eXaudios, as saying.

“If a customer is screaming, you don”t need the software. But if we can identify the other emotions of a customer, we can save customers and companies money,” Levanon added.

Certain diseases have an unmistakable impact on a person”s speech. Many autistic patients require speech therapy to communicate effectively. Nearly 90 percent of Parkinson”s disease patients eventually develop some form of soft, mumbled speech.

Yoram Bonneh, an autism researcher at the Weizman Institute of Science in Israel, used the Magnify software in his work with autistic five-year-old children.

Out of 80 children – 40 previously diagnosed with autism and 40 non-autistic children – Magnify successfully identified 85 percent of the autistic kids.

In addition to autism study, eXaudios cites other research in Parkinson”s disease, schizophrenia, heart disease and dyslexia.

The company even has anecdotal evidence that they can diagnose prostate cancer by analyzing a person”s voice. (ANI)

Stressful jobs up women”s heart disease risk

Washington, May 6 (ANI): High-pressure jobs increase young women”s risk of heart disease, concludes a new study.

In the study, published in Occupational and Environmental Medicine, the research team assessed the impact of work pressure and degree of personal influence in the workplace on the heart health of 12,116 nurses, who were taking part in the Danish Nurse Cohort Study.

The nurses were all aged between 45 and 64 in 1993, when they were quizzed about their daily work pressures and personal influence, after which their health was then tracked for 15 years, using hospital records.

By 2008, 580 nurses had been admitted to hospital with ischaemic heart disease, which included 369 cases of angina and 138 heart attacks.

Nurses who indicated that their work pressures were a little too high were 25 percent more likely to have ischaemic heart disease as those who said their work pressures were manageable and appropriate.

But those who felt work pressures were much too high were almost 50 percent more likely to have ischaemic heart disease. After taking account of risk factors for heart disease, such as smoking and lifestyle, the risk fell to 35 percent, but still remained significant.

Poor job control in the workplace did not influence heart disease risk, while the amount of physical activity at work, which is known to affect health, had a small although significant impact.

When the findings were analysed by age, only the nurses under the age of 51 were at significant risk of heart disease.

In a separate analysis, the researchers looked at the impact of work pressures on the same group, but for just five years up to 1998.

Nurses who felt themselves to be moderately pressurised at work were 60 percent more likely to have ischaemic heart disease while those who said they faced excessive pressures at work were almost twice as likely to have it.

These findings held true even after taking account of other risk factors.

“It seems as if the effect of work pressure has a greater impact on younger nurses,” say the authors. “This is in agreement with findings from previous studies looking at age specific effects in both men and women.”

“The lower risk among the older nurses may be due to other risk factors that become relatively more important with increasing age. Furthermore, vulnerable individuals may have [already] left work,” they add. (ANI)

New approach helps pinpoint genes behind common diseases

Washington, Apr 30 (ANI): Challenging the long-held view that common diseases are usually caused by common gene variants (mutations), researchers have now said that the culprits may be numerous rare variants.

And these variants are located in DNA sequences farther away from the original “hot spots” than scientists have been accustomed to look.

Using an approach that detects rare but powerful causal gene variants, the researchers say they have accounted for a significant proportion of the “missing heritability” problem.

This refers to the disappointing fact that, to date, conventional gene-hunting studies have often failed to identify, when searching for gene variants, variants that cause a large proportion of common diseases, such as heart disease, cancers and diabetes.

The new approach draws on existing data from genome-wise association studies (GWAS) that have already been performed, re-analysing the data to pinpoint causal variants that have not been identified previously.

In addition, the technique may allow researchers to identify individuals whose DNA is more likely to carry specific mutations in the causal genes.

“Our approach draws us closer to the goal of personalized medicine, in which treatment will be tailored to an individual”s genetic profile. When we can say that a specific gene mutation causes a patient”s disease, we have more meaningful diagnostic results. Identifying causal variants in disease genes provides an opportunity to develop drugs to rectify the biological consequences of these mutated genes,” said study leader Dr. Hakon Hakonarson, director of the Center for Applied Genomics at The Children”s Hospital of Philadelphia.

By applying their methods to real DNA samples from patients with genetic hearing loss, the researchers” approach helped them to select from GWAS data a subset of cases for sequencing analysis that were most likely to carry causative mutations.

Sequencing the DNA in this subset, the study team found that the majority of those patients carried an actual mutation known to cause hearing loss.

“Our technique suggests that when we do our resequencing follow-up studies, we can identify people who are much more likely to carry a causative gene,” said Kai Wang, who analyzed the dataset.

Hakonarson added: “We present a more efficient approach for mining GWAS data to find the actual causative gene variants that will have future utility in designing therapies.”

The study appears online in The American Journal of Human Genetics. (ANI)

“Human guinea pig” scientist sequences own genome to predict health risks!

London, Apr 30 (ANI): A “human guinea pig” boffin is the world’s first person to have all his DNA screened for unknown disease risk factors.

Professor Stephen Quake, an American scientist, subjected himself to the test.

His test results revealed heightened risks of heart disease, cardiac arrest, diabetes and prostate cancer, as well as information about likely responses to certain medicines, reports The Daily Express.

Quake said: “We”re at the dawn of a new age of genomics. Information like this will enable doctors to deliver personalised health care like never before.”

Quake, from Stanford University School of Medicine, came in the limelight last year when he used new technology to sequence his own genome, or genetic code, for less than 50,000 US dollars.

The new study, published in The Lancet medical journal, used Quake”s personal genetic data to make predictions about the fate of his health. (ANI)

America needs more vitamin D, say experts

Washington, April 28 (ANI): Milk is America”s top source of the much-needed vitamin D, a new study has revealed.

Using the latest national data (NHANES 2003-2006) on what more than 16,000 Americans ages two and older eat, researchers investigated the contribution of each food group to the total vitamin D intake.

No other food item came close to the vitamin D contribution of milk.

In fact, for kids ages 2 to eighteen, milk provided nearly two-thirds of all vitamin D in the diet.

Dr. Keith Ayoob, a registered dietician and paediatric nutrition expert, said: “There are few true replacements for the nutrient package you find in one glass of fat free or lowfat milk.

“Without milk in the diet, it”s hard to meet a number of nutrient needs – most notably vitamin D.”

Many Americans are not getting enough vitamin D, and this D-ficiency may put their health at risk.

Well known for its role in keeping bones strong, vitamin D is now being hailed for so much more.

Emerging science suggests vitamin D may also help protect against diabetes, hypertension, heart disease and certain cancers. It also supports a healthy immune system.

Despite a potential upside of boosting vitamin D levels, Americans of all ages still fall short of their vitamin D needs.

In fact, current deficiency levels prompted the American Academy of Pediatrics to double the vitamin D recommendations for children and teens.

The Academy estimates that up to half of adolescents have low vitamin D levels.

Experts recommend 400IU of vitamin D each day – the amount in four glasses of fat free or lowfat milk.

The study was presented at the Experimental Biology conference in Anaheim, California. (ANI)

Tart cherries reduce inflammation, risk for heart disease

Washington, Apr 28 (ANI): Tart cherries do have powerful anti-inflammatory benefits, claims a new study by Michigan researchers.

The researchers used a “whole food” approach to find that a cherry-enriched diet not only reduced overall body inflammation, but also reduced inflammation at key sites (belly fat, heart) known to affect heart disease risk in obese, at-risk rats.

At-risk obese rats were fed a cherry-enriched “Western Diet,” characterized by high fat and moderate carbohydrate – in line with the typical American diet – for 90 days.

Cherry-enriched diets, which consisted of whole tart cherry powder as 1 percent of the diet, reduced risk factors for heart disease including cholesterol, body weight, fat mass and known markers of inflammation.

While inflammation is a normal process the body uses to fight off infection or injury, scientists have said that a chronic state of inflammation increases the risk for diseases.

“Chronic inflammation is a whole body condition that can affect overall health, especially when it comes to the heart. This study offers further promise that foods rich in antioxidants, such as cherries, could potentially reduce inflammation and have the potential to lower disease risk,” said study co-author Dr. Mitch Seymour.

A second pilot study found similar results in humans.

Ten overweight or obese adults drank eight ounces of tart cherry juice daily for four weeks.

At the end of the trial, there were significant reductions in several markers of inflammation, in addition to lower levels of triglycerides, another key risk factors for heart disease.

Researchers say both studies are encouraging and will lead to further clinical studies in humans to explore the link between diet, inflammation and lowering disease risk.

The new study is the latest linking cherries to protection against heart disease and inflammation.

According to researchers, it”s the anthocyanins – powerful antioxidant compounds in cherries – also responsible for the fruit”s bright red color, that link cherries to reduced inflammation, even inflammation related to muscle recovery post-exercise.

Due to their availability throughout the year, cherries—dried, frozen and juice forms— could be incorporated into the daily diet to help manage inflammation.

The study has been presented at the Experimental Biology annual meeting. (ANI)

Grapes cut risk factors for heart disease and diabetes

Washington, Apr 27 (ANI): Grape consumption can lower blood pressure, improve heart function and reduce other risk factors for heart disease and metabolic syndrome, according to a new study.

The effect is thought to be due to phytochemicals — naturally occurring antioxidants – that grapes contain, say the study”s researchers.

The study will be presented today at the Experimental Biology convention in Anaheim, Calif..

The research shows encouraging results of a grape-enriched diet preventing risk factors for metabolic syndrome.

To reach the conclusion, researchers studied the effect of regular table grapes (a blend of green, red and black grapes) that were mixed into a powdered form and integrated into the diets of laboratory rats as part of a high-fat, American style diet. All of the rats used were from a research breed that is prone to being overweight.

They performed many comparisons between the rats consuming a grape-enriched diet and the control rats receiving no grape powder. Researchers added calories and sugars to the control group to balance the extra calories and sugars gained from getting the grape powder.

After three months, the rats that received the grape-enriched diet had lower blood pressure, better heart function, and reduced indicators of inflammation in the heart and the blood than rats who received no grape powder. Rats also had lower triglycerides and improved glucose tolerance.

The effects were seen even though the grape-fed animals had no change in body weight.

In all, researchers say the study demonstrates that a grape-enriched diet can have broad effects on the development of heart disease and metabolic syndrome and the risk factors that go along with it.

“The possible reasoning behind the lessening of metabolic syndrome is that the phytochemicals were active in protecting the heart cells from the damaging effects of metabolic syndrome. In the rats, inflammation of the heart and heart function was maintained far better,” says Steven Bolling, M.D., heart surgeon at the U-M Cardiovascular Center and head of the U-M Cardioprotection Research Laboratory.

The researchers also looked for signs of inflammation, oxidative damage and other molecular indicators of cardiac stress. Again, the rats who consumed the grape powder had lower levels of these markers than rats who did not receive grapes.

There is no well-accepted way to diagnose metabolic syndrome which is really a cluster of characteristics: excess belly fat (for men, a waist measuring 40 inches or more and for women, a waist measuring 35 inches or more); high triglycerides which can lead to plague build-up in the artery walls; high blood pressure; reduced glucose tolerance; and elevated c-reactive protein, a marker for inflammation in the body.

Those with metabolic syndrome are at higher risk for cardiovascular disease and type 2 diabetes.

But the U-M study suggests that it may be possible that grape consumption can change the downhill sequence that leads to heart disease by prolonging the time between when symptoms begin to occur and a time of diagnosis.

“Reducing these risk factors may delay the onset of diabetes or heart disease, or lessen the severity of the diseases,” says E. Mitchell Seymour, Ph.D., lead researcher and manager of the U-M Cardioprotection Research Laboratory. “Ultimately it may lessen the health burden of these increasingly common conditions.” (ANI)

Lung virus behind pneumonia kills 200,000 kids worldwide annually

London, Apr 16 (ANI): A University of Edinburgh study has shown a common virus that causes wheezing and pneumonia claims the lives of up to two hundred thousand children worldwide each year.

The study, published in the Lancet, also showed that about 3.4 million children require hospital treatment for severe lung infection caused by the bug – respiratory syncytial virus (RSV).

RSV – which infects most children before the age of two – usually causes mild cold-like symptoms, but can lead to serious illness in babies who are born prematurely or who have congenital heart disease.

The study confirms that RSV is the single largest cause of lung infection in children.

Dr Harish Nair, of the University of Edinburgh”s Department of Population Health Studies, said: “Our greatest hope of fighting this virus is to develop a vaccine, but before we can implement an immunisation programme, we need to understand exactly how big a problem RSV poses.

“This is the first time we have gathered information on such a global scale and is the best estimate we have for the number of children dying each year from this preventable illness.”(ANI)